Aerie Pharmaceuticals to Participate in Two Investor Conferences in December

IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that company management will participate in the following conferences in December. Citi 2016 Global Healthcare Conference Attendee: Richard Rubino, Chief Financial Officer Date: Thursday, December 8, 2016 Location: New York, NY BMO Capital Markets 2016 Prescription for